Ir.catalystpharma.com

Investors : Catalyst Pharmaceutical

WebInvestor Menu. Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing …

Actived: Just Now

URL: https://ir.catalystpharma.com/

Catalyst Pharmaceuticals Reports Strong Fourth Quarter …

WebAchieved Record 2023 Total Revenues of $398.2 Million, an 85.9% Increase Compared to 2022 Achieved Record Fourth Quarter 2023 Total Revenues of $110.6 …

Category:  Health Go Health

Catalyst Pharmaceuticals Announces Publication of …

WebSanthera's Study Reports the Results of the 48-Week Treatment with Vamorolone in Patients with Duchenne Muscular Dystrophy (DMD) in the VISION-DMD …

Category:  Health Go Health

Catalyst Pharmaceuticals Announces FDA Acceptance of …

WebThe sNDA Seeks to Increase the Indicated Maximum Daily Dose for FIRDAPSE to 100mg for the Treatment of Lambert-Eaton Myasthenic Syndrome. U.S. …

Category:  Health Go Health

Catalyst Pharmaceuticals to Present at MDA Clinical

WebCORAL GABLES, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical …

Category:  Health Go Health

Catalyst Pharmaceuticals to Participate at the BofA …

WebThe webcast will be available under the Investors section on the Company's website, www.catalystpharma.com, and a replay will be available for at least 14 days. …

Category:  Health Go Health

Catalyst Pharmaceuticals Announces AGAMREE® Now …

WebAGAMREE ® (vamorolone) a Novel Alternative Corticosteroid with Demonstrated Properties in Maintaining Efficacy and a Well-Tolerated Side Effect Profile. …

Category:  Health Go Health

Catalyst Pharmaceuticals Announces FIRDAPSE® New …

WebCORAL GABLES, Fla., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company …

Category:  Health Go Health

Catalyst Pharmaceuticals Reports that the FDA Marketing …

WebEarlier this Week the District Court Granted Summary Judgement to Catalyst in Its Lawsuit Against the FDA and this FDA Action is the Result of that Decision CORAL …

Category:  Health Go Health

Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year …

WebTotal 2021 Revenues Increased Approximately 18% YoY to $141 Million Strong 2022 Revenue Growth Expected, Supported by FIRDAPSE ® Orphan Drug …

Category:  Health Go Health

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial …

WebThe Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ET. CORAL GABLES, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- …

Category:  Health Go Health

Catalyst Pharmaceuticals Expands Leadership Team with …

WebCORAL GABLES, Fla., July 06, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical …

Category:  Health Go Health

Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year …

WebDecember 31, 2022 December 31, 2021 ASSETS Current Assets: Cash and cash equivalents $ 298,395 $ 171,445: Short-term investments -- 19,821

Category:  Health Go Health

Catalyst Pharmaceuticals to Present at the Cowen 40th Annual …

WebCORAL GABLES, Fla., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company …

Category:  Health Go Health

Catalyst Pharmaceuticals to Participate at the Piper Sandler 33rd

WebCORAL GABLES, Fla., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical …

Category:  Health Go Health

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes …

WebCatalyst Ranked #4 on the List. CORAL GABLES, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") …

Category:  Health Go Health

Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual

WebThe presentation webcast will be available on the Investors section of the Company's website, and a replay will be accessible for at least 14 days.. About Catalyst …

Category:  Health Go Health

Catalyst Pharmaceuticals’ Firdapse® (amifampridine phosphate) …

WebCORAL GABLES, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company …

Category:  Health Go Health

Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering …

WebCORAL GABLES, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or the “Company”) (Nasdaq: CPRX) announced today that it has …

Category:  Health Go Health

Brian Elsbernd : Management Team : Catalyst Pharmaceutical

WebBrian Elsbernd joined Catalyst as the Senior Vice President of Legal and Compliance in February 2016. Prior to joining Catalyst, Mr. Elsbernd was Senior Director of US …

Category:  Health Go Health

David Caponera : Management Team : Catalyst Pharmaceutical

WebDavid J. Caponera joined Catalyst in October 2014 as our Vice President, Patient Engagement and Access Support. Mr. Caponera has over 30 years of successful …

Category:  Health Go Health